Just like normal vaccines, RNA vaccines are intended to induce the production of antibodies which will bind to potential pathogens. The RNA sequence codes for antigens, proteins that are identical, or resembling those of the pathogen. Upon the delivery of the vaccine into the body, this sequence is translated by the host cells to produce the encoded antigens, which then stimulate the body’s adaptive immune system to produce antibodies against the pathogen.
Links To The Developers
- Baiya Phytopharm/ Chula Vaccine Research Center
- CanSino Biologics/Precision NanoSystems
- Centro Nacional Biotecnología (CNB-CSIC), Spain
- China CDC/Tongji University/Stermina
- Chula Vaccine Research Center/University of Pennsylvania
- FBRI SRC VB VECTOR, Rospotrebnadzor, Koltsovo
- Fudan University/ Shanghai JiaoTong University/RNACure Biopharma(2)
- Fudan University/ ShanghaiJiaoTong University/RNACure Biopharma
- Greenlight Biosciences
- IDIBAPS-Hospital Clinic, Spain
- Imperial College London
- RNAimmune, Inc.
- Translate Bio/Sanofi Pasteur
- University of Tokyo/ Daiichi-Sankyo